Trial intelligence / Profile preview

PROPER-1: Subcutaneous vs Vaginal Progesterone Preference

NCT03734770Completed

Sponsor
Università degli Studi di Verona
Start
Jan 2019
Primary completion
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of Luteon in infertility (2 arms), sponsored by Università degli Studi di Verona. Primary endpoints: Grade of use satisfaction reported by the patients at 14 days, Grade of quality of life impairment reported by the patients at 14 days and 1 more. Started Jan 2019; status: completed.

02

Drugs

Luteon
03

Conditions

infertility

Beyond the preview

Go deeper on NCT03734770.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03734770.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call